UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer

Journal of cancer research and therapeutics, 2023-12, Vol.19 (Suppl 2), p.S747-S751

2023

Volltextzugriff (PDF)

Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19

European journal of cancer (1990), 2021-07, Vol.152, p.248-249

2021

Volltextzugriff (PDF)

Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer

Supportive care in cancer, 2020-11, Vol.28 (11), p.5235-5242

2020

Volltextzugriff (PDF)

Exploring the connection between microsatellite instability and inflammatory indicators in cancers

Future oncology (London, England), 2024-01, Vol.20 (2), p.95-105

2024

Volltextzugriff (PDF)

Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study

Journal of gastrointestinal cancer, 2024-03, Vol.55 (1), p.281-286

2024

Volltextzugriff (PDF)

Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors

Future oncology (London, England), 2022-02, Vol.18 (4), p.413-416

2022

Volltextzugriff (PDF)

Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities

Current oncology reports, 2024-07, Vol.26 (7), p.791-803

2024

Volltextzugriff (PDF)

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study

Annals of surgical oncology, 2024-09, Vol.31 (9), p.6228-6236

2024

Volltextzugriff (PDF)

ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis

Future oncology (London, England), 2021-01, Vol.17 (3), p.349-357

2021

Volltextzugriff (PDF)

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors

Anti-cancer drugs, 2022-11, Vol.33 (10), p.1145-1149

2022

Volltextzugriff (PDF)

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Journal of oncology pharmacy practice, 2020-07, Vol.26 (5), p.1289-1294

2020

Volltextzugriff (PDF)

Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients

Anti-cancer drugs, 2024-02, Vol.35 (2), p.190

2024

Volltextzugriff (PDF)

The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib

Future oncology (London, England), 2022-03, Vol.18 (9), p.1067-1076

2022

Volltextzugriff (PDF)

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data

Dermatologic therapy, 2021-11, Vol.34 (6), p.e15122-n/a

2021

Volltextzugriff (PDF)

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Journal of gastrointestinal cancer, 2022-12, Vol.53 (4), p.870-879

2022

Volltextzugriff (PDF)

Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?

Journal of oncology pharmacy practice, 2021-03, Vol.27 (2), p.450-452

2021

Volltextzugriff (PDF)

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

European journal of cancer (1990), 2020-12, Vol.141, p.92-104

2020

Volltextzugriff (PDF)

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis

Critical reviews in oncology/hematology, 2021-10, Vol.166, p.103463-103463, Article 103463

2021

Volltextzugriff (PDF)

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study

European journal of clinical pharmacology, 2022-12, Vol.78 (12), p.1973-1979

2022

Volltextzugriff (PDF)

First-line crizotinib in ALK-positive lung cancer

The New England journal of medicine, 2015-02, Vol.372 (8), p.781

2015

Volltextzugriff (PDF)

Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer

Combinatorial chemistry & high throughput screening, 2021-01, Vol.24 (8), p.1229-1235

2021

Volltextzugriff (PDF)

Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors

Immunotherapy, 2024-07, Vol.16 (12), p.821-828

2024

Volltextzugriff (PDF)

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

Journal of oncology pharmacy practice, 2020-07, Vol.26 (5), p.1110-1116

2020

Volltextzugriff (PDF)

mRNA-based COVID-19 vaccines appear to not increase immune events in cancer patients receiving immune checkpoint inhibitors

Future virology, 2021-09, Vol.16 (9), p.583-585

2021

Volltextzugriff (PDF)

Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors

The Prostate, 2022-11, Vol.82 (15), p.1456-1461

2022

Volltextzugriff (PDF)

1 – 25 von 165

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(133)

Publikationsform

Artikel
(165)

Sprache

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(89)
Science & Technology
(89)
Humans
(70)
Oncology
(60)
Female
(40)
Middle Aged
(38)
Male
(35)
Adult
(26)
Aged
(24)
Retrospective Studies
(18)
Cancer
(17)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(16)
Chemotherapy
(16)
Medicine
(16)
Medicine & Public Health
(14)
Patients
(14)
Prognosis
(14)
Metastases
(13)
Metastasis
(13)
Aged, 80 And Over
(12)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Distributions and prognostic effects of ABO/Rh blood groups in patients with HER2/neu positive gastric and gastroesophageal junction cancer

Response to letter entitled: Re: A systematic review and meta-analysis: The effect of active cancer treatment on severity of COVID-19

Prevalence, etiology and risk factors of anemia in patients with newly diagnosed cancer

Exploring the connection between microsatellite instability and inflammatory indicators in cancers

Relationship Between ABO Blood Group and Microsatellite Instability in Colorectal Cancer: A Retrospective Single-Center Study

Key considerations and common adverse events for HIV-positive patients with cancer treated with immune checkpoint inhibitors

Advancements in the Management of Synchronous Colorectal Liver Metastases: A Comprehensive Review of Surgical, Systemic, and Local Treatment Modalities

Analysis of Treatment Strategies and Outcomes in Malignant Peritoneal Mesothelioma: Insights From a Multi-Center Study

ctDNA as a prognostic factor in operable colon cancer patients: a systematic review and meta-analysis

Chronic hyperglycemia based on diabetes is independently associated with decreased survival in patients with advanced cancer treated with immune checkpoint inhibitors

Clinical course of COVID-19 infection in elderly patient with melanoma on nivolumab

Impact of antihistamine use on the survival outcomes of immune checkpoint inhibitors in advanced cancer patients

The prognostic role of polypharmacy in metastatic colorectal cancer patients treated with regorafenib

Efficacy and tolerability of vismodegib treatment in locally advanced and metastatic basal cell carcinoma: Retrospective real‐life data

Systemic Immune-Inflammation Index as a Prognostic Marker of Late Recurrence in Operable Gastric Cancer: a Dual-Center Study

Commentary: Should all cancer patients be tested for COVID-19 before each chemotherapy cycle?

A systematic review and meta-analysis: the effect of active cancer treatment on severity of COVID-19

Neurotoxicities of novel non-steroidal anti-androgens for prostate cancer: A systematic review and meta-analysis

Clinical outcomes of concomitant use of proton pump inhibitors and regorafenib in patients with metastatic colorectal cancer: a multicenter study

First-line crizotinib in ALK-positive lung cancer

Osteopontin is a Prognostic Factor in Patients with Advanced Gastric Cancer

Impact of low sodium values on survival outcomes of patients with cancer receiving immune checkpoint inhibitors

The relationship between prognostic nutritional index and treatment response in patients with metastatic renal cell cancer

mRNA-based COVID-19 vaccines appear to not increase immune events in cancer patients receiving immune checkpoint inhibitors

Prognostic role of pan‐immune‐inflammation value in patients with metastatic castration‐resistant prostate cancer treated with androgen receptor‐signaling inhibitors

Suchergebnisse filtern